← FDA Drug Approvals (Drugs@FDA)

SULFA-TRIPLE #2

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS · Approved 1974-01-23

Drug application

FDA Application #

ANDA080079

Application type

Abbreviated New Drug Application (Generic)

Brand name

SULFA-TRIPLE #2

Generic name

Trisulfapyrimidines (Sulfadiazine

Active ingredients

TRISULFAPYRIMIDINES (SULFADIAZINE; SULFAMERAZINE; SULFAMETHAZINE)

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

IMPAX LABS

First approval

1974-01-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown